Granza Bio
YC W24 · Active · Building programmable therapeutics for the immune system
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCS22 | |
| Other | Active | YCW24 | |
| Other | Active | YCW23 | |
| Other | Active | YCS24 | |
| Other | Active | YCW24 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW24 | |
| Other | Active | YCS19 | |
| Other | Acquired | YCW22 | |
| Other | Active | YCW22 | |
| Other | Inactive | YCS18 |
Also from W24
All of W24About Granza Bio
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.
- YC batch
- W24 · Winter 2024
- Status, per YC
- Active
- Category
- Other
- Team size
- 8
- Location
- San Francisco, CA, USA
- Checked
- 34m ago
YC tags: Synthetic Biology, Biotech, Healthcare, Therapeutics, Oncology
Granza Bio: questions
Which YC batch was Granza Bio in?
Granza Bio was in Y Combinator's Winter 2024 batch (W24).
Is Granza Bio still active?
Y Combinator lists Granza Bio as active.
Where is Granza Bio based?
Granza Bio lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.